Description
System for oritavancin susceptibility testing with the broth microdilution method, according to ISO 20776-1.
Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive bacteria, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), and enterococci. ComASP® Oritavancin 0.001-16 is a 2-test panel containing the dried-up antibiotic in 15 two-fold dilutions:
Disclaimer: This product is for laboratory use only.Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.